Hybrid Event | Tuesday 27 January 2026 | Paris, France and livestreamed via Zoom
Hosted by the International Pandemic Preparedness Secretariat (IPPS) in partnership with ANRS MIE/Inserm and the Pasteur Network
Click here to register to attend virtually
About the launch
On 27 January 2026, IPPS will host the global launch of the Fifth Implementation Report of the 100 Days Mission, convened in Paris in collaboration with the French National Research Agency for HIV, Viral Hepatitis, Tuberculosis and Emerging Infectious Diseases (ANRS MIE/Inserm) and the Pasteur Network. This year’s report assesses progress throughout 2025 against a backdrop of multiple outbreaks, including H5N1, Dengue, Chikungunya, Ebola, Rift Valley Fever, and resurgent measles and pertussis, alongside the continued mpox health emergency in Africa.
As the world moves toward major milestones in 2026, including France’s G7 Presidency, the One Health Summit, and the UN High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR), the Fifth Implementation Report asks a central question: Are we closer to ensuring rapid, equitable access to diagnostics, therapeutics and vaccines (DTVs) within 100 days of a newly detected pandemic threat?
This event will:
- Publicly launch the 2025 Implementation Report and 100 Days Mission Scorecard 3.0, outlining progress in DTV development and priority actions for 2026.
- Strengthen cross-pillar alignment across diagnostics, therapeutics, vaccines, clinical trials and regulatory systems.
- Catalyse collaboration around the Therapeutics Development Coalition (TxDC) ahead of its Spring 2026 launch.
- Build consensus around investment and innovation priorities emerging from the 2025 Global Diagnostics Gap Assessment.
- Advance dialogue on vaccine equity, regional production and distributed manufacturing.
- Illustrate the societal value of preparedness, from innovation and job creation to strengthened health systems.
The event will be hybrid and livestreamed via Zoom. Register for virtual attendance here.
Programme
All times shown in Central European Time (CET)
09:00–09:30
Welcome & Opening Remarks
09:30–10:30 – Session 1
100 Days Mission Fifth Implementation Report Findings
This session brings together members of the IPPS Science & Technology Expert Group (STEG) and IPPS Steering Group to present the key findings of the Fifth Implementation Report. Speakers will examine how diagnostics, therapeutics, vaccines, clinical trials and regulatory systems must work in concert—not in silos—to accelerate innovation and deployment.
10:30–10:45 – Refreshment Break
10:45–11:45 – Session 2
Closing the Gap in R&D: Building a Global Development Coalition for Therapeutics
Therapeutics remain one of the most underdeveloped components of the 100 Days Mission. This session will outline the goals of the Therapeutics Development Coalition (TxDC) and highlight how a coordinated global approach can accelerate antiviral innovation, strengthen collaboration, and support equitable access.
11:45–12:45 – Session 3
Diagnostics: The First Line of Defence for Health
Drawing from the 2025 Global Diagnostics Gap Assessment, this panel will explore how to close persistent gaps in funding, coordination, innovation, and deployment. Speakers will discuss how diagnostics can be better integrated with vaccines and therapeutics for a coherent preparedness architecture.
12:45–13:45 – Lunch Break
13:45–14:45 – Session 4
Turning Innovation into Impact: Advancing Vaccine Equity
This session examines how scientific innovation can be translated into equitable vaccine access, with a focus on regional production, distributed manufacturing, and the new Global Coalition on Regional Production, Innovation and Access.
14:45–15:45 – Session 5
From Global Commitment to Local Prosperity: Driving Impact Through Preparedness
Preparedness drives long-term societal value—from innovation ecosystems and job creation to resilient health systems. This session explores how investments in DTVs and emerging technologies can deliver national benefits while strengthening global readiness.
15:45–16:00 — The Way Forward
Closing remarks from Dr Mona Nemer, Chair of IPPS and Chief Science Advisor of Canada
Contact
- General enquiries: info@ippsecretariat.org
- Media enquiries: Ashley Giles, Senior Strategic Engagement Adviser – a.giles@ippsecretariat.org